Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

257 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3300 (92%)

3571

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2020-02-05 2020-03-11 105359
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2024-05-24 2024-07-19 228777
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2023-05-26 2023-06-02 193209
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2019-08-21 2019-12-07 92035
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2025-06-12 2025-07-25 260147
APO-TAMOX TAB 20MG 20MG TABLET Resolved 2017-09-04 2017-11-27 20909
APO-TAMOX TAB 20MG 20MG TABLET Resolved 2024-04-12 2024-05-24 224990
APO-TAMOX TAB 20MG 20MG TABLET Resolved 2024-06-13 2024-07-19 230480
APO-TAMOX TAB 20MG 20MG TABLET Resolved 2019-05-15 2019-12-09 84154
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-17 2017-10-24 15995
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-06 2023-04-21 188973
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-02 2021-02-23 123581
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-28 2025-05-21 205480
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-05-10 2017-05-13 9946
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-17 2021-02-23 124359
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-26 2017-11-13 17331
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-07 2021-02-23 125824
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE TABLETS 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-FLUVOXAMINE TABLETS 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971